<DOC>
	<DOCNO>NCT01662232</DOCNO>
	<brief_summary>Cardiovascular disease major cause morbidity mortality worldwide . Impaired endothelial function ( assessed flow-mediated dilation ) represent early marker later cardiovascular event . Epidemiological experimental study suggest consumption tea associate low progression atherosclerosis reduce cardiovascular mortality . Tea contain high amount polyphenols important biological activity . The green tea catechin epigallocatechin-3-gallate ( EGCG ) potent physiologically active compound vitro . However , little known contribution beneficial effect tea vivo . In crossover study impact single dose EGCG apply different form ( green tea beverage , green tea extract EGCG ) flow-mediated dilation investigate healthy volunteer two hour ingestion . The amount EGCG ( 200 mg ) correspond appr . 0.5 L green tea . The result study elucidate contribution EGCG cardiovascular protective effect green tea vivo . The outcome provide insight role EGCG different application form improvements endothelial function human .</brief_summary>
	<brief_title>Improvement Endothelial Function EGCG</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>Male healthy volunteer 2050 year BMI &lt; 27 kg/m2 Cholesterol &lt; 240 mg/dl Diabetes mellitus Hypertension Conditions impair endothelial function Smoking Regular drug use Alcohol abuse Regular tea drinker</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Green tea</keyword>
	<keyword>EGCG</keyword>
	<keyword>Cardiovascular disease</keyword>
	<keyword>Endothelial function</keyword>
	<keyword>Flow-mediated dilation</keyword>
</DOC>